MEGGLE Excipients & Technology signed an agreement with Quadra Chemicals Ltd., a leading chemical and ingredient distributor, to represent its excipient portfolio for the Pharmaceutical and Nutraceutical industries in Canada effective August 1st, 2019.
“Quadra’s industry knowledge, customer-focus and capabilities make them the ideal partner to distribute our excipient product portfolio in Canada,” said Ruth Leinenbach, Director, BG Excipients & Technology. “This strategic partnership will enable us to efficiently service the market and our customers in Canada.”
“Quadra is proud to represent MEGGLE, a global producer of high-quality Lactose excipients” said Christine Infilise, Vice President Ingredients at Quadra. “As a complement to our existing high-quality product offerings and our focused sales team, we look forward to meeting the diverse Lactose excipient needs of Canada’s Pharmaceutical and Nutraceutical manufacturers.”
About MEGGLE AG: With headquarters in the Bavarian city of Wasserburg (Germany), serves as a holding company for various business activities in the dairy industry and whey processing. MEGGLE has a proud history of more than 130 years in the dairy market.
The business group Excipients & Technology produces pharmaceutical excipients for direct compression, granulation, capsules, sachets, powder blends and dry powder inhalers. With its broad product portfolio, intelligent innovations and exceptional product quality, MEGGLE took a leading role in the global business of pharmaceutical excipients. With production facilities in Wasserburg (Germany) and Le Sueur, Minnesota (USA), where we serve the requirements of the North American market, MEGGLE is prepared to meet customer expectations worldwide.